How I treat fragile myeloma patients.

Blood
Alessandra Larocca, Antonio Palumbo

Abstract

Multiple myeloma is a disease typical of elderly people, with a median age at diagnosis of 70 years. Much progress has been made in the past few years thanks to the introduction of new drugs. However, increases in survival were much less pronounced in patients aged 60 to 69 years, and no improvement was seen in older patients. Furthermore, the currently approved treatment regimens were tested in clinical trials with stringent inclusion criteria. Aging is associated with a high prevalence of frailty, that is, a state of increased vulnerability to stressors due to a critical decline in physiologic reserves. Elderly people may be categorized as fit or frail according to clinical, functional, cognitive, and socioeconomic criteria. The presence of frailty may complicate the management and outcome of myeloma patients. To date, the choice of treatment of myeloma patients has focused primarily on chronological age and performance status as markers of frailty. However, the elderly population is highly heterogeneous, and improved assessment strategies are needed to define the frailty profile of patients and provide them with the most adequate treatment, thus avoiding the overtreatment of frail patients and the undertreatment of fit patie...Continue Reading

References

Sep 1, 1989·Journal of Inorganic Biochemistry·C Adams, P A Adams
Dec 30, 1999·The New England Journal of Medicine·L F HutchinsK S Albain
Dec 13, 2003·The Hematology Journal : the Official Journal of the European Haematology Association·Brian G M DurieUNKNOWN Scientific Advisors of the International Myeloma Foundation
Mar 20, 2004·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Linda P FriedGerard Anderson
Jul 21, 2006·Leukemia·B G M DurieUNKNOWN International Myeloma Working Group
Nov 23, 2007·The New England Journal of Medicine·Meletios DimopoulosUNKNOWN Multiple Myeloma (010) Study Investigators
Nov 23, 2007·The New England Journal of Medicine·Donna M WeberUNKNOWN Multiple Myeloma (009) Study Investigators
Aug 30, 2008·The New England Journal of Medicine·Jesús F San MiguelUNKNOWN VISTA Trial Investigators
Apr 25, 2009·Seminars in Hematology·Efstathios KastritisMeletios A Dimopoulos
May 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Benjamin D SmithThomas A Buchholz
May 20, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cyrille HulinPhilippe Moreau
Aug 18, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Michael SchaapveldEdo Vellenga
Feb 10, 2010·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Alan Katz, Anne Katz
May 8, 2010·Blood·Anders WaageUNKNOWN Nordic Myeloma Study Group
Jun 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre WijermansUNKNOWN Dutch-Belgium Cooperative Group HOVON
Jul 21, 2010·Blood·Jayesh MehtaSeema Singhal
Mar 18, 2011·The New England Journal of Medicine·Antonio Palumbo, Kenneth Anderson
Jan 25, 2012·Blood·Heinz LudwigUNKNOWN International Myeloma Working Group
Feb 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrzej J JakubowiakKenneth C Anderson
May 11, 2012·The New England Journal of Medicine·Antonio PalumboUNKNOWN MM-015 Investigators
May 31, 2012·Blood·Philippe MoreauJean-Luc Harousseau
Apr 5, 2013·Therapeutic Advances in Hematology·Marìa-Victoria Mateos, Jesús F San Miguel
Jun 7, 2014·Expert Opinion on Investigational Drugs·Sara BringhenAntonio Palumbo
Jul 22, 2014·Patient Preference and Adherence·Maria Teresa PetrucciFabiana Gentilini
Sep 4, 2014·The New England Journal of Medicine·Lotfi BenboubkerUNKNOWN FIRST Trial Team
Dec 3, 2014·The Lancet Oncology·S Vincent RajkumarJesus F San Miguel
Dec 9, 2014·The New England Journal of Medicine·A Keith StewartUNKNOWN ASPIRE Investigators

❮ Previous
Next ❯

Citations

Oct 26, 2016·Future Oncology·Dharshan SivarajCristina Gasparetto
Mar 6, 2015·Expert Review of Hematology·Helena Maes, Michel Delforge
Sep 8, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alessandra Larocca, Antonio Palumbo
May 16, 2017·Expert Review of Hematology·Sonja Genadieva StavricAlessandra Larocca
Apr 28, 2017·Expert Opinion on Investigational Drugs·Mattia D'AgostinoFrancesca Gay
Jul 1, 2017·Expert Opinion on Pharmacotherapy·Fabrizio EsmaChiara Pautasso
Jul 5, 2018·Expert Review of Anticancer Therapy·Marco SalviniSara Bringhen
Jul 7, 2017·Blood·Jean Luc Harousseau, Michel Attal
May 20, 2020·British Journal of Haematology·Ciara L Freeman, Joseph Mikhael
Dec 21, 2017·Expert Review of Hematology·Hussein G Elsayed, Amal S Alabdulwahab
Mar 21, 2018·Drugs & Aging·Hira S Mian, Tanya M Wildes
Mar 27, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Claudio CerchioneLucio Catalano
Mar 22, 2018·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Francesco SparanoFabio Efficace
Nov 25, 2018·Annals of Hematology·Hartmut GoldschmidtLaurent Garderet
Apr 10, 2019·Annals of Hematology·Cristina JoãoPaulo Lúcio
Aug 24, 2017·Journal of Clinical Pharmacy and Therapeutics·P HariV A Morrison
Mar 2, 2019·Current Hematologic Malignancy Reports·Saurabh ZanwarPrashant Kapoor
Mar 21, 2017·Clinical Journal of Oncology Nursing·Tracy King, Beth Faiman
Sep 26, 2017·Clinical Journal of Oncology Nursing·Sandra RomeTeresa Miceli
Apr 14, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Á RovirosaA Torne
May 28, 2019·Current Oncology Reports·Crystal Antoine-Pepeljugoski, Marc Justin Braunstein
Oct 13, 2020·Hematology Reports·Daniele DerudasClaudio Cerchione
Jun 30, 2019·BMJ Supportive & Palliative Care·Michela ServadioFabio Efficace
Feb 6, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert Z Orlowski, Sagar Lonial
Oct 14, 2020·Journal of Geriatric Oncology·Henry ChanSharon Jackson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Aging

This feed focuses on cellular aging with emphasis on mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.